Pacific Edge Ltd (PEB)

Snapshot

PEB's Principal Activity is the development and deployment of specialist cancer diagnostics tools.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Mr David George Darling	Chief Executive Officer,Executive Director	N/A	Mr David George Darling Chief Executive Officer,Executive Director Mr Darling has over 30 years of business experience in life sciences and biotechnology. He has executive and leadership experience in the development and international commercialisation of biomedical and biotechnology businesses and products. During his career, he has held a number of positions in governance, executive and senior management, joining Pacific Edge from Fletcher Challenge. He is also a member of Capital Committee.
Mr Anatole Masfen	Non-Executive Director	N/A	Mr Anatole Masfen Non-Executive Director Mr Masfen is the co-founder of Artemis Capital, a private equity investment firm based in Auckland. He has spent eight years with Air New Zealand (and later the merged entity with Ansett Australia) holding senior positions in Pricing, Revenue Management and Systems implementation. He holds directorships in numerous private companies and has knowledge of financial capital markets. He also has a detailed knowledge of the medical sector and future trends. In particular human sciences and disruptive technologies. He is also a Chair of Capital Committee and member of Risk committee.
Dr Bryan Raymond George Williams	Non-Executive Director	N/A	Dr Bryan Raymond George Williams Non-Executive Director Dr Williams is an internationally recognised cancer researcher and research administrator, with business experience. He has held a number of governance roles, including with a NASDAQ listed biotech company. Presently, he serves on the Board of two privately held Australian biotechnology companies. He was Director and CEO of the Hudson Institute of Medical Research. He is currently Emeritus Director and Distinguished Scientist at the Hudson Institute in Melbourne.
Mr Christopher (Chris) John Gallaher	Non-Executive Chairman,Non-Executive Director	N/A	Mr Christopher (Chris) John Gallaher Non-Executive Chairman,Non-Executive Director Mr Gallaher has held senior positions in both CEO and CFO roles with a number of international companies and was a partner in Arthur Young, Chartered Accountants. Prior to retiring from full time corporate life, he was CFO of Fulton Hogan, a NZ resources based civil contractor. He is also Chairman of Mariposa Holdings, a charitable organisation. He is also a member of Risk & Capital committee.
Ms Sarah Natalie Park	Non-Executive Director	N/A	Ms Sarah Natalie Park Non-Executive Director Ms Park has international corporate finance experience with PricewaterhouseCoopers in New Zealand and HSBC Investment Bank in London. During her executive career, she worked in M&A, equity capital markets and was previously an Equity Research Analyst. She also had a lead role in seeking private capital from Asia, the Middle East and Europe for early-stage US biopharmaceutical companies. Ms Park is a Director of National Provident Fund and Hawke's Bay Airport. She has a focus on providing her Audit & Risk capability and experience to her directorship portfolio. She is also chair of Risk Committee and a member of Capital Committee.
Ms Anna Kate Stove	Non-Executive Director	N/A	Ms Anna Kate Stove Non-Executive Director Ms Stove has a 25+ year track record in leading and driving transformational change within the pharmaceutical sector. She has Global business experience having held a variety of senior executive roles within NZ, Asia Pacific and Europe. She recently retired from being NZ General Manager at GlaxoSmthKline & she is now committed to growing businesses through best practice governance. She is currently the Chair of Global Women, Director of TAB NZ & Director of Rua Bioscience.
Mr Mark Green	Non-Executive Director	N/A	Mr Mark Green Non-Executive Director Mr Green is an experienced corporate finance professional, with 25 years of experience in the Australasian capital, corporate and financial markets. He was an Executive Director for Investment Banking at Goldman Sachs where he worked for nearly 20 years and has been involved in many New Zealand transactions including the IPOs of Meridian, Mighty River Power and Vector. He is a Director of a number of entities including being Chair of Astrolab VC Investment Committee and a Director of Mariposa Holdings (a charitable organisation).
Mr Grant Edward Gibson	Chief Financial Officer,Company Secretary	N/A

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Mark Green	N/A	N/A	N/A	N/A	N/A
Anna Stove	N/A	N/A	N/A	N/A	N/A
Sarah Park	N/A	N/A	N/A	N/A	N/A
Christopher (Chris) Gallaher	N/A	N/A	N/A	N/A	N/A
Bryan Williams	N/A	N/A	N/A	N/A	N/A
Anatole Masfen	N/A	N/A	N/A	N/A	N/A
David Darling	N/A	N/A	N/A	N/A	N/A

Show All

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

PEB Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.